Nanostructured materials for inhibition of bacterial adhesion in orthopedic implants: A minireview

International Journal of Artificial Organs

Volumn 31, Issue 9, 2008, Pages 771-776

  Montanaro, L ^a,b   Campoccia, D ^a   Arciola, Carla Renata ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bacterial adhesion; Nanostructured materials; Orthopedic implants; Osseointegration

Indexed keywords

ADHESION; BONE; CELL CULTURE; COLLAGEN; INTERFACES (MATERIALS); OSTEOBLASTS;

BACTERIAL ADHESION; BONE IMPLANT; IMPLANT INTERFACES; IMPLANT MATERIALS; INTERFACE GENERATION; ORTHOPAEDIC IMPLANTS; OSSEOINTEGRATION; STRESS AND STRAIN; TISSUE IMPLANTS; WEAR DEBRIS;

NANOSTRUCTURED MATERIALS;

ALUMINUM OXIDE; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; FIBRONECTIN; HYDROXYAPATITE; NANOMATERIAL; NANOPARTICLE; NANOTUBE; POLYETHYLENE; POLYGLACTIN; POLYURETHAN; TITANIUM; TITANIUM DIOXIDE; VITRONECTIN;

BACTERIUM ADHERENCE; BIOCOMPATIBILITY; BONE PROSTHESIS; BONE REGENERATION; CELL ADHESION; CERAMIC PROSTHESIS; EQUIPMENT DESIGN; INFECTION PREVENTION; NONHUMAN; OSTEOBLAST; PROSTHESIS FAILURE; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRESS STRAIN RELATIONSHIP; SURFACE PROPERTY;

EID: 56349152635     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100904     Document Type: Review

References (31)

1. Sato M, Webster TJ. Nanobiotechnology: implications for the future of nanotechnology in orthopaedic applications. Expert Rev Med Devices 2004; 1: 105-14.
2. Abu-Amer Y, Darwech I, Clohisy JC. Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 2007; 9 (Suppl 1): S6.
3. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006; 27: 2331-9.
4. Williams DF. On the mechanisms of biocompatibility. Biomaterials 2008; 29: 2941-53.
5. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996; 12: 697-715.
6. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res 2000; 51: 475-83.
7. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng 2001; 7: 291-301.
8. Bustanji Y, Arciola CR, Conti M, Mandello E, Montanaro L, Samorí B. Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc Natl Acad Sci U S A 2003 11; 100: 13292-7.
9. Arciola CR, Bustanji Y, Conti M, Campoccia D, Baldassarri L, Samorì B, Montanaro L. Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials 2003; 24: 3013-9.
10. Campoccia D, Montanaro L, Agheli H, Sutherland DS, Pirini V, Donati ME, Arciola CR. Study of Staphylococcus aureus adhesion on a novel nanostructured surface by chemiluminometry. Int J Artif Organs 2006; 29: 622-9.
11. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007; 28: 4880-8.
12. Shi Z, Neoh KG, Kang ET, Wang W. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 2006; 27: 2440-9.
13. Mohammadi Y, Soleimani M, Fallahi-Sichani M, Gazme A, Haddadi-Asl V, Arefian E, Kiani J, Moradi R, Atashi A, Ahmadbeigi N. Nanofibrous poly(epsilon-caprolactone)/poly(vinyl alcohol)/chitosan hybrid scaffolds for bone tissue engineering using mesenchymal stem cells. Int J Artif Organs 2007; 30: 204-11.
14. Nair LS, Laurencin CT. Nanofibers and nanoparticles for orthopaedic surgery applications. J Bone Joint Surg (Am) 2008; 90 (Suppl 1): S128-31.
15. Rameshbabu N, Sampath Kumar TS, Prabhakar TG, Sastry VS, Murty KV, Prasad Rao K. Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J Biomed Mater Res A 2007; 80: 581-91.
16. Tsuang YH, Sun JS, Huang YC, Lu CH, Chang WH, Wang CC. Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif Organs 2008; 32: 167-74.
17. Ben-Nissan B, Choi AH. Sol-gel production of bioactive nanocoatings for medical applications. Part 1: an introduction. Nanomed 2006; 1: 311-9.
18. Choi AH, Ben-Nissan B. Sol-gel production of bioactive nanocoatings for medical applications. Part II: current research and development. Nanomed 2007; 2: 51-61.
19. Gupta R, Kumar A. Bioactive materials for biomedical applications using sol-gel technology. Biomed Mater 2008; 3: 34005.
20. Charville GW, Hetrick EM, Geer CB, Schoenfisch MH. Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release. Biomaterials 2008; 29: 4039-44.
21. Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A 2006; 78: 595-604.
22. Schuler M, Owen GR, Hamilton DW, de Wild M, Textor M, Brunette DM, Tosatti SGP. Biomimetic modification of titanium dental implant model surfaces using the RGD-SP-peptide sequence: A cell morphology study. Biomaterials 2006; 27: 4003-15.
23. VandeVondele S, Voros J, Hubbell JA. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng 2003; 82: 784-90.
24. Tosatti S, Paul SMD, Askendal A, VandeVondele S, Hubbell JA, Tengvall P, Textor M. Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials 2003; 24: 4949-58.
25. Harris LG, Tosatti S, Wieland M, Textor M, Richards RG. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionatized and peptide-functionalized poly(L-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004; 25: 4135-48.
26. Variola F, Yi JH, Richert L, Wuest JD, Rosei F, Nanci A. Tailoring the surface properties of Ti6Al4V by controlled chemical oxidation. Biomaterials 2008; 29: 1285-98.
27. Powell MC, Kanarek MS. Nanomaterials health effects-Part 1: background and current knowledge. Wis Med J 2006; 105: 16-20.
28. Powell MC, Kanarek MS. Nanomaterials health effects-Part 2: uncertainties and recommendations for the future. Wis Med J 2006; 105: 18-23.
29. Tamura K, Takashi N, Akasaka T, et al. Effects of micro/nano particle size on cell function and morphology. Key Eng Mater 2004; 254/256: 919-22.
30. Liu Y, Hunziker EB, Layrolle P, De Bruijn JD, De Groot K. Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity. Tissue Eng 2004; 10: 101-8.
31. Stigter M, Bezemer J, DeGroot K, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004; 99: 127-37.